GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study.
Villa E, Donghia R, Baldaccini V, Tedesco CC, Shahini E, Cozzolongo R, Ascari S, Pesole PL, Coletta S, Critelli RM, Lasagni S, Schepis F, Semellini F, Giannelli G.
Villa E, et al. Among authors: ascari s.
Hepatol Commun. 2023 Sep 15;7(10):e0262. doi: 10.1097/HC9.0000000000000262. eCollection 2023 Oct 1.
Hepatol Commun. 2023.
PMID: 37708455
Free PMC article.